Press Release Forum [pressreleaseforum.com] Forum Index

Press Release Forum [pressreleaseforum.com]
Free Press Release Distribution

A site of EPR Network

 FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   Log in to check your private messagesLog in to check your private messages   Log inLog in 

Real Time Press Release Distribution is here. Try it out, it's free!

 

Axcellerate Pharma, New Jersey aims to become a market leade

 
Post new topic   Reply to topic    Press Release Forum [pressreleaseforum.com] Forum Index -> General Press Releases
View previous topic :: View next topic  
Author Message
EPR Network
Site Admin


Joined: 31 Jan 2006
Posts: 31987

PostPosted: Wed Nov 20, 2013 2:51 pm    Post subject: Axcellerate Pharma, New Jersey aims to become a market leade Reply with quote

Axcellerate Pharma, New Jersey aims to become a market leader in high-value, niche offerings to the US life sciences industry

Released on: November 20, 2013, 1:10 pm
Author: TCG Lifesciences Limited
Industry: Biotech
November 20, 2013, 1:10 pm -- /EPR NETWORK/ -- Axcellerate Pharma establishes CMO/CRO and API manufacturing facility in New Jersey, US. Focus will be small molecule and biologics PR&D, innovative technology platforms, filling vial and bag operations, peptide synthesis, oligonucleotide production and related areas.

Axcellerate Pharma LLC (“Axcellerate”) is a JV set up by TCG Lifesciences USA LLC, an affiliate of TCG Lifesciences Limited, a leading CRO engaged in drug development and clinical trial services; with Dilip Mehta, Founder & CEO of PANORAMA Consulting and Engineering, Inc., a leading developer of lab scale to GMP manufacturing facilities; and Alfagen Pharma LLC, an affiliate of AlfaGene Bioscience, Inc., an innovative biotechnology company. The facility houses state-of-the-art technology/equipment/ infrastructure and is supported by leading industry personnel from each of the partner firms.

"We will initially target specialized CMC and CMO activities that are time sensitive and high value in nature, that are desirable to be located geographically close to our clients. Axcellerate intends to leverage the strong scientific talent pool, end-to-end capabilities and PR&D/intermediate production facilities of TCG Lifesciences Limited in India to support its operations. This opportunity represents another significant milestone for TCG Lifesciences' continued expansion,” commented Swapan Bhattacharya, Managing Director of TCG Lifesciences “as this strategic alliance will expand TCG Lifesciences' geographic footprint and enable us to service clients in the US with a local presence while being supported globally”.

Dilip Mehta, CEO and co-founder of Axcellerate commented “we will engineer the facilities to provide the highest level of efficiency, technology and cost effectiveness to our customers, given PANORAMA's broad involvement and experience in all facets of the pharma/biotech sector. We are pleased to join hands with TCG Lifesciences, who will bring in the scientific and technical know how and expertise in the cutting edge areas of drug discovery and development.”

“AlfaGene Bioscience has developed proprietary assay platforms in a range of therapeutic indications and has a scientific team with extensive experience in biologics and biomedical research. We also have a network of global relationships in the API arena to bring to bear for the success of Axcellerate”, remarked Mayur Doshi, President and CEO, AlfaGene Bioscience.

About TCG Lifesciences Limited
TCGLS are a leading contract research services company in the area of drug discovery and early development. The company employs 675+ trained scientists, drawn from the best national and international institutes and industry. Their services span from specific discovery, preclinical and clinical development solutions to integrated drug development programs across multiple therapeutic areas of Central Nervous System (CNS), Inflammation and Pain, Metabolic Disorders and Infectious Diseases.

For more information about TCG, please visit: www.tcgls.com

About PANORAMA Consulting & Engineering, Inc.
PANORAMA is a full - service EPCMCV (Engineering, Procurement, Construction Management, Commissioning and Validation) company, offering services in the Pharmaceutical, Bio-Pharmaceutical, Nano-Technology, Chemical, Specialty Chemical, Polymer and Petrochemical Industries. Their clients range from Big Pharma to small start-ups finding their footing in the industry. With a highly qualified and diverse staff well rounded to deal with numerous engineering and project management challenges, Panorama has served major companies, with projects ranging from large-scale facilities to laboratories for drug development purposes. They also provide process development and scale-up services to take your research to the next level and help you through the entire process from inception to mass production.

For more information about Panorama, please visit: www.panoramaus.com
Contact:

Mr. Swapan Bhattachrya (swapan.bhattacharya@tcgls.com)
Mr. Dilip Mehta (dilip.mehta@axcelleratepharma.com)
Mr. Sandro La Rosa (sandro.larosa@axceleratepharma.com)
Back to top
View user's profile Send private message
Display posts from previous:   
Post new topic   Reply to topic    Press Release Forum [pressreleaseforum.com] Forum Index -> General Press Releases All times are GMT - 4 Hours
Page 1 of 1

 
Jump to:  
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot vote in polls in this forum

Submit Press Release (Free)Submit Press Release